One Hundred Two Consecutive Hepatobiliary Resections for Perihilar Cholangiocarcinoma With Zero Mortality
- 1 August 2006
- journal article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 244 (2) , 240-247
- https://doi.org/10.1097/01.sla.0000217605.66519.38
Abstract
To analyze the short-term surgical outcome of hepatobiliary resections for perihilar cholangiocarcinoma in the last 5 years. Hepatobiliary resection for perihilar cholangiocarcinoma remains a technically demanding procedure, calling for a high level of expertise in biliary and hepatic surgery, and is still associated with significant morbidity or mortality. Between 2000 and 2004, we surgically treated 102 consecutive patients with perihilar cholangiocarcinoma with a management strategy consisting of preoperative biliary drainage, portal vein embolization (for right-sided and extended left-sided resections), and major hepatobiliary resection. The data on all of the patients were analyzed retrospectively to identify the factors that might significantly affect the postoperative mortality and morbidity. There were no cases of in-hospital mortality or postoperative liver failure. Major complications were encountered in 7 patients (6.9%), and the overall morbidity rate was 50%. Reoperation was required in 2 patients (2%). The overall median length of postoperative hospital stay was 26 days (range, 13–119 days). Univariate analysis in relation to the postoperative morbidity showed significant differences in the preoperative occurrence of segmental cholangitis or cholecystitis (P = 0.015), the severity of postoperative hyperbilirubinemia (P < 0.001), and the total amount of fresh frozen plasma administered (P = 0.002). Multivariate analysis revealed a single independent significant predictive factor for postoperative morbidity, namely, preoperative cholangitis or cholecystitis (odds ratio, 9.08; 95% confidence interval, 1.05–78.56, P = 0.045). Our experience indicates that hepatobiliary resections for perihilar cholangiocarcinoma can be conducted safely, without a single case of postoperative liver failure or mortality. Occurrence of preoperative cholangitis or cholecystitis is a significant indicator for morbidity of major hepatobiliary resection.Keywords
This publication has 34 references indexed in Scilit:
- One hundred consecutive hepatobiliary resections for biliary hilar malignancy: Preoperative blood donation, blood loss, transfusion, and outcomeSurgery, 2005
- Improving Perioperative Outcome Expands the Role of Hepatectomy in Management of Benign and Malignant Hepatobiliary DiseasesAnnals of Surgery, 2004
- Forty Consecutive Resections of Hilar Cholangiocarcinoma With No Postoperative Mortality and No Positive Ductal MarginsAnnals of Surgery, 2004
- Hepatectomy With Portal Vein Resection for Hilar CholangiocarcinomaAnnals of Surgery, 2003
- Results of Surgical Resection for Patients With Hilar Bile Duct CancerAnnals of Surgery, 2003
- Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experienceJournal of Hepato-Biliary-Pancreatic Surgery, 2000
- One hundred and eleven liver resections for hilar bile duct cancerJournal of Hepato-Biliary-Pancreatic Surgery, 2000
- Surgical treatment for hilar cholangiocarcinomaJournal of Hepato-Biliary-Pancreatic Surgery, 2000
- Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma—a single center experience☆Surgery, 2000
- Preoperative intrahepatic segmental cholangitis in patients with advanced carcinoma involving the hepatic hilusSurgery, 1996